Análogos de ácido barbitúrico como agentes terapeuticos

"ANáLOGOS DE áCIDO BARBITúRICO COMO AGENTES TERAPEUTICOS". A presente invenção se refere a análogos de ácido barbitúricos os quais inibem a atividade de HIF-1 (por exemplo, a interação entre o HIFl e p300) e, dessa forma, inibem a angiogênese, tumorigênese e condições proliferativas tal co...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: STEPHEN RYLEY, JACKIE Y. DE BELIN, PAUL W. FINN, DAVID C. BILLINGTON, LEE G. SAYERS, MARIA-ROSARIO ROMERO-MARTIN, SHOUMO BHATTACHARYA, NORMAN M. LAW
Format: Patent
Sprache:por
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator STEPHEN RYLEY
JACKIE Y. DE BELIN
PAUL W. FINN
DAVID C. BILLINGTON
LEE G. SAYERS
MARIA-ROSARIO ROMERO-MARTIN
SHOUMO BHATTACHARYA
NORMAN M. LAW
description "ANáLOGOS DE áCIDO BARBITúRICO COMO AGENTES TERAPEUTICOS". A presente invenção se refere a análogos de ácido barbitúricos os quais inibem a atividade de HIF-1 (por exemplo, a interação entre o HIFl e p300) e, dessa forma, inibem a angiogênese, tumorigênese e condições proliferativas tal como câncer. A presente invenção também se refere a composições farmacêuticas compreendendo tais compostos e ao uso de tais compostos e composições, in vitro e in vivo, para inibir a atividade de HIF-1 e inibir a angiogênese, tumorigênese e condições proliferativas tal como câncer. This invention pertains to active barbituric acid analogs which inhibit HIF-1 activity (e.g., the interaction between HIF-1$g(a) and p300) and thereby inhibit angiogenesis, tumorigenesis, and proliferative conditions, such as cancer. The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit HIF-1 activity, and to inhibit angiogenesis, tumorigenesis, and proliferative conditions, such as cancer.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_BR0111438A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BR0111438A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_BR0111438A3</originalsourceid><addsrcrecordid>eNrjZLByzDu8MCc_Pb9YISVV4fDC5MyUfIWkxKKkzJLDu4oyk_MVkvNz8xUS01PzSlKLFUpSixILUktLgBLFPAysaYk5xam8UJqbQd7NNcTZQze1ID8-tbggMTk1L7Uk3inIwNDQ0MTYwtGYsAoAwnIwVQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Análogos de ácido barbitúrico como agentes terapeuticos</title><source>esp@cenet</source><creator>STEPHEN RYLEY ; JACKIE Y. DE BELIN ; PAUL W. FINN ; DAVID C. BILLINGTON ; LEE G. SAYERS ; MARIA-ROSARIO ROMERO-MARTIN ; SHOUMO BHATTACHARYA ; NORMAN M. LAW</creator><creatorcontrib>STEPHEN RYLEY ; JACKIE Y. DE BELIN ; PAUL W. FINN ; DAVID C. BILLINGTON ; LEE G. SAYERS ; MARIA-ROSARIO ROMERO-MARTIN ; SHOUMO BHATTACHARYA ; NORMAN M. LAW</creatorcontrib><description>"ANáLOGOS DE áCIDO BARBITúRICO COMO AGENTES TERAPEUTICOS". A presente invenção se refere a análogos de ácido barbitúricos os quais inibem a atividade de HIF-1 (por exemplo, a interação entre o HIFl e p300) e, dessa forma, inibem a angiogênese, tumorigênese e condições proliferativas tal como câncer. A presente invenção também se refere a composições farmacêuticas compreendendo tais compostos e ao uso de tais compostos e composições, in vitro e in vivo, para inibir a atividade de HIF-1 e inibir a angiogênese, tumorigênese e condições proliferativas tal como câncer. This invention pertains to active barbituric acid analogs which inhibit HIF-1 activity (e.g., the interaction between HIF-1$g(a) and p300) and thereby inhibit angiogenesis, tumorigenesis, and proliferative conditions, such as cancer. The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit HIF-1 activity, and to inhibit angiogenesis, tumorigenesis, and proliferative conditions, such as cancer.</description><edition>7</edition><language>por</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2003</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20030617&amp;DB=EPODOC&amp;CC=BR&amp;NR=0111438A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20030617&amp;DB=EPODOC&amp;CC=BR&amp;NR=0111438A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>STEPHEN RYLEY</creatorcontrib><creatorcontrib>JACKIE Y. DE BELIN</creatorcontrib><creatorcontrib>PAUL W. FINN</creatorcontrib><creatorcontrib>DAVID C. BILLINGTON</creatorcontrib><creatorcontrib>LEE G. SAYERS</creatorcontrib><creatorcontrib>MARIA-ROSARIO ROMERO-MARTIN</creatorcontrib><creatorcontrib>SHOUMO BHATTACHARYA</creatorcontrib><creatorcontrib>NORMAN M. LAW</creatorcontrib><title>Análogos de ácido barbitúrico como agentes terapeuticos</title><description>"ANáLOGOS DE áCIDO BARBITúRICO COMO AGENTES TERAPEUTICOS". A presente invenção se refere a análogos de ácido barbitúricos os quais inibem a atividade de HIF-1 (por exemplo, a interação entre o HIFl e p300) e, dessa forma, inibem a angiogênese, tumorigênese e condições proliferativas tal como câncer. A presente invenção também se refere a composições farmacêuticas compreendendo tais compostos e ao uso de tais compostos e composições, in vitro e in vivo, para inibir a atividade de HIF-1 e inibir a angiogênese, tumorigênese e condições proliferativas tal como câncer. This invention pertains to active barbituric acid analogs which inhibit HIF-1 activity (e.g., the interaction between HIF-1$g(a) and p300) and thereby inhibit angiogenesis, tumorigenesis, and proliferative conditions, such as cancer. The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit HIF-1 activity, and to inhibit angiogenesis, tumorigenesis, and proliferative conditions, such as cancer.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2003</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLByzDu8MCc_Pb9YISVV4fDC5MyUfIWkxKKkzJLDu4oyk_MVkvNz8xUS01PzSlKLFUpSixILUktLgBLFPAysaYk5xam8UJqbQd7NNcTZQze1ID8-tbggMTk1L7Uk3inIwNDQ0MTYwtGYsAoAwnIwVQ</recordid><startdate>20030617</startdate><enddate>20030617</enddate><creator>STEPHEN RYLEY</creator><creator>JACKIE Y. DE BELIN</creator><creator>PAUL W. FINN</creator><creator>DAVID C. BILLINGTON</creator><creator>LEE G. SAYERS</creator><creator>MARIA-ROSARIO ROMERO-MARTIN</creator><creator>SHOUMO BHATTACHARYA</creator><creator>NORMAN M. LAW</creator><scope>EVB</scope></search><sort><creationdate>20030617</creationdate><title>Análogos de ácido barbitúrico como agentes terapeuticos</title><author>STEPHEN RYLEY ; JACKIE Y. DE BELIN ; PAUL W. FINN ; DAVID C. BILLINGTON ; LEE G. SAYERS ; MARIA-ROSARIO ROMERO-MARTIN ; SHOUMO BHATTACHARYA ; NORMAN M. LAW</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_BR0111438A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>por</language><creationdate>2003</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>STEPHEN RYLEY</creatorcontrib><creatorcontrib>JACKIE Y. DE BELIN</creatorcontrib><creatorcontrib>PAUL W. FINN</creatorcontrib><creatorcontrib>DAVID C. BILLINGTON</creatorcontrib><creatorcontrib>LEE G. SAYERS</creatorcontrib><creatorcontrib>MARIA-ROSARIO ROMERO-MARTIN</creatorcontrib><creatorcontrib>SHOUMO BHATTACHARYA</creatorcontrib><creatorcontrib>NORMAN M. LAW</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>STEPHEN RYLEY</au><au>JACKIE Y. DE BELIN</au><au>PAUL W. FINN</au><au>DAVID C. BILLINGTON</au><au>LEE G. SAYERS</au><au>MARIA-ROSARIO ROMERO-MARTIN</au><au>SHOUMO BHATTACHARYA</au><au>NORMAN M. LAW</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Análogos de ácido barbitúrico como agentes terapeuticos</title><date>2003-06-17</date><risdate>2003</risdate><abstract>"ANáLOGOS DE áCIDO BARBITúRICO COMO AGENTES TERAPEUTICOS". A presente invenção se refere a análogos de ácido barbitúricos os quais inibem a atividade de HIF-1 (por exemplo, a interação entre o HIFl e p300) e, dessa forma, inibem a angiogênese, tumorigênese e condições proliferativas tal como câncer. A presente invenção também se refere a composições farmacêuticas compreendendo tais compostos e ao uso de tais compostos e composições, in vitro e in vivo, para inibir a atividade de HIF-1 e inibir a angiogênese, tumorigênese e condições proliferativas tal como câncer. This invention pertains to active barbituric acid analogs which inhibit HIF-1 activity (e.g., the interaction between HIF-1$g(a) and p300) and thereby inhibit angiogenesis, tumorigenesis, and proliferative conditions, such as cancer. The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit HIF-1 activity, and to inhibit angiogenesis, tumorigenesis, and proliferative conditions, such as cancer.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language por
recordid cdi_epo_espacenet_BR0111438A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Análogos de ácido barbitúrico como agentes terapeuticos
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T13%3A59%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=STEPHEN%20RYLEY&rft.date=2003-06-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EBR0111438A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true